Mining data, gathering variables and recombining information: the flexible architecture of epidemiological studies

Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical Sciences

Volumn 39, Issue 4, 2008, Pages 415-428

  Bauer, Susanne ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biobanks; Breast cancer aetiology; Collecting; Data mining; Population registries; Risk factor epidemiology

Indexed keywords

ARTICLE; BREAST TUMOR; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; FACTUAL DATABASE; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; METHODOLOGY; QUESTIONNAIRE;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; DATA COLLECTION; DATABASES, FACTUAL; EPIDEMIOLOGIC METHODS; EPIDEMIOLOGIC STUDIES; EPIDEMIOLOGY, MOLECULAR; HUMANS; INFORMATION STORAGE AND RETRIEVAL; QUESTIONNAIRES; RESEARCH DESIGN;

EID: 56349167561     PISSN: 13698486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.shpsc.2008.09.008     Document Type: Article

References (131)

1. Ahmed M., and Rahman N. ATM and breast cancer susceptibility. Oncogene 25 (2006) 5906-5911
2. Amsterdamska O. Demarcating epidemiology. Science, Technology, and Human Values 30 1 (2005) 17-51
3. Andersen T.F., Madsen M., Jørgensen J., Mellemkjoer L., and Olsen J.H. The Danish National Hospital Register: A valuable source of data for modern health sciences. Danish Medical Bulletin 46 3 (1999) 263-268
4. Antoniou A.C., and Easton D.F. Models of genetic susceptibility to breast cancer. Oncogene 25 (2006) 5898-5906
5. Antoniou A.C., Pharoah P.D.P., Easton D.F., and Evans D.G. BRCA1 and BRCA2 cancer risk. Journal of Clinical Oncology 24 29 (2006) 3312-3313
6. Appadurai A. Introduction: Commodities and the politics of value. In: Appadurai A. (Ed). The social life of things (1988), Cambridge University Press, Cambridge 3-63
7. Appleyard M. The Copenhagen City Heart Study. Østerbroundersøgelsen. A book of tables with data from the first examination (1976-1978) and a five year follow-up (1981-1983). Scandinavian Journal of Social Medicine Suppl. 41 (1989) 1-160
8. Aronowitz R.A. Making sense of illness. Science, society, and disease (1998), Cambridge University Press, Cambridge
9. Bauer S. The genomics of environmental response: Re/visions in risk assessment?. In: Bammé A., Getzinger G., and Wieser B. (Eds). Yearbook 2006 of the Institute for Advanced Studies on Science, Technology and Society (2006), Profil, Munich/Vienna 121-138
10. Bech-Danielsen, A. (1998). Pesticider gav brystkræft. Politiken, 5 December, Sect. 1, 5.
11. Bell D.W., Varley J.M., Szydlo T.E., Kang D.H., Wahrer D.C., Shannon K.E., Lubratovich M., Verselis S.J., Isselbacher K.J., Fraumeni J.F., Birch J.M., Li F.P., Garber J.E., and Haber D.A. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286 (1999) 2528-2531
12. In: Berkman L., and Kawachi I. (Eds). Social epidemiology (2000), Oxford University Press, New York
13. Berlivet L. Argumentation scientifique et espace publique: La quête de l'objectivité dans les controversies autour de 'risque de santé'. In: Francois B., and Neveu E. (Eds). Espaces publics mosai{dotless}̈ques: Acteurs, arènes et rhétoriques des débats publics contemporains (1999), Presses Universitaires de Rennes, Rennes 185-208
14. Berlivet L. 'Association or causation'? The debate on the scientific status of epidemiology, 1945-c.1965. In: Berridge V. (Ed). Making health policy: Networks in research and policy after 1945 (2005), Rodopi, Amsterdam 43-74
15. Berlivet L. Exigence scientifique et isolement institutionnel: L'essor contrarié de l'épidémiologie française dans la seconde moitié du XXe siècle. In: Jorland G., Opinel A., and Weisz G. (Eds). Body counts: Medical quantification in historical & sociological perspectives (2005), McGill-Queen's University Press, Montreal 335-358
16. Berridge V. Making health policy: Networks in research and policy after 1945 (2005), Rodopi, Amsterdam
17. Bourret P. BRCA patients and clinical collectives: New configurations of action in cancer genetics practices. Social Studies of Science 35 1 (2005) 41-68
18. Breslow, N. E., & Day, N. E. (1980). Statistical methods in cancer research, Vol. I. The analysis of case-control studies. IARC Scientific Publications, 32. Lyon: ARC.
19. Breslow, N. E., & Day, N. E. (1987). Statistical methods in cancer research, Vol. II. The design and analysis of cohort studies. IARC Scientific Publications, 82. Lyon.
20. Brody J.G., and Rudel R.A. Environmental pollutants and breast cancer. Environmental Health Perspectives 111 8 (2003) 1007-1019
21. Brown P., McCormick S., Mayer B., Zavestocki S., Morello-Frosch R., Gasior Altmann R., and Senier L. 'A lab of our own': Environmental causation of breast cancer and challenges to the dominant epidemiological paradigm. Science, Technology, and Human Values 31 (2006) 499-536
22. Cambrosio A., Keating P., Schlich T., and Weisz G. Regulatory objectivity and the generation and management of evidence in medicine. Social Science and Medicine 63 1 (2006) 189-199
23. Chadarevian S.de. Following molecules: Hemoglobin between the clinic and the laboratory. In: deChadarevian S., and Kamminga H. (Eds). Molecularizing biology and medicine: New practices and alliances, 1910-1970s (1998), Harwood, Amsterdam 171-201
24. Chen S., Iversen E.S., Friebel T., Finkelstein D., Webe B.L., Eisen A., Peterson L.E., Schildkraut J.M., Isaacs C., Peshkin B.N., Corio C., Leondaridis L., Tomlinson G., Dutson D., Kerber R., Amos C.I., Strong L.C., Berry D.A., Euhus D.M., and Parmigiani G. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. Journal of Clinical Oncology 24 6 (2006) 863-871
25. Copenhagen City Heart Study. (n.d.). http://www.copenhagencityheartstudy.dk/sider/artikler.htm. (Accessed 15 May 2008)
26. In: Daston L. (Ed). Things that talk (2005), Zone books, Cambridge MA
27. Daston L., and Galison P. The image of objectivity. Representations 50 (1992) 81-128
28. Dawber T.R., Meadors G.F., and Moore Jr. F.E. Epidemiological approaches to heart disease: The Framingham Study. American Journal of Public Health 4 3 (1951) 279-281
29. Deleuze G., and Guattari F. A thousand plateaus (1988), Athlone, London
30. Desrosières A. The politics of large numbers: A history of statistical reasoning (1998), Harvard University Press, Cambridge MA
31. Dørge, H. (1998). En giftig sag. Weekendavisen, 23 October, section1, 4.
32. Einarsdottir K., Rosenberg L.U., Humphreys K., Bonnard C., Palmgren J., Li Y., Li Y., Chia K.S., Liu E.T., Hall P., Liu J., and Wedren S. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: A population-based case-control and follow-up study. Breast Cancer Research 8 (2006) R67
33. Ejlertsen B., and Gerdes A.-M. Arvelig brystkræft: Behandling og forebyggelse. Ugeskrift for Læger 169 (2007) 2972
34. ERICA Research Group. (1988). The CHD Risk-Map of Europe: The 1st Report of the WHO-ERICA Project. European Heart Journal, 9(Suppl. I), 1-36.
35. Feinstein A.R. Clinical epidemiology: The architecture of clinical research (1985), Saunders, Philadelphia
36. Fischerman K., and Mouridsen H.T. Danish Breast Cancer Cooperative Group (DBCG). Structure and results of the organization. Acta Oncologica 27 (1988) 593-596
37. Fisher R.A. Statistical methods for research workers (1925), Tweeddale Court, Edinburgh
38. Fisherman K., and Mouridsen H.T. Danish Breast Cancer Cooperative Group (DBCG). Ugeskrift Læger 139 42 (1977) 2493-2494
39. Foucault M. The birth of the clinic: An archaeology of medical perception (1973), Tavistock, London
40. Frank L. Epidemiology: When an entire country is a cohort. Science 287 5462 (2000) 2398-2399
41. Frank L. Epidemiology: The epidemiologist's dream: Denmark. Science 301 5630 (2003) 163
42. Gaudillière J.-P. Introduction: Drug trajectories. Studies in History and Philosophy of Biological and Biomedical Sciences 36 4 (2005) 603-611
43. 'Genpub', University of Copenhagen. (n.d.). http://genpub.pubhealth.ku.dk/postgeno_en/Public_Health_Genomics/. (Accessed 15 May 2008)
44. Gerdes A.-M. Presse, etik og genetisk screening. Ugeskrift for Læger 168 40 (2006) 3448
45. Hacking I. The taming of chance (1990), Cambridge University Press, Cambridge
46. Hagerup L., Eriksen M., Schroll M., Hollnagel H., Agner E., and Larsen S. The Glostrup Population Studies collection of epidemiologic tables. Reference values for use in cardiovascular population studies. Scandinavian Journal of Social Medicine Suppl. 20 (1981) 1-112
47. In: Heesen A.te., and Spary E. (Eds). Sammeln als Wissen (2001), Wallstein, Göttingen
48. Henderson B., Pike M., Bernstein L., and Ross R. Breast cancer. In: Schottenfeld D., and Fraumeni J.F. (Eds). Cancer epidemiology and prevention (1996), Oxford University Press, New York 1022-1039
49. Hill A.B. The environment and disease: Association or causation. Proceedings of the Royal Society of Medicine 58 (1965) 295-300
50. Hill A.B. Principles of medical statistics (1971), The Lancet Limited, London (First published 1937)
51. Hine C. Databases as scientific instruments and their role in the ordering of scientific work. Social Studies of Science 36 2 (2006) 269-298
52. Høyer A.P., Jørgensen T., Grandjeau P., Brock J.W., and Hartvig H.B. Organochlorine exposure and breast cancer. Lancet 352 (1998) 1816-1820
53. Høyer A.P., Jørgensen T., Grandjeau P., and Brock J.W. Organochlorine exposure and breast cancer survival. Journal of Clinical Epidemiology 52 (2000) 323-330
54. Høyer A.P., Jørgensen T., Grandjeau P., and Hartvig H.B. Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control 11 (2000) 177-184
55. Høyer A.P., Grandjeau P., Jørgensen T., Brock J.W., and Hartvig H.B. Organiske klorede forbindinger og brystkræft. Ugeskrift Læger 162 7 (2000) 922-926
56. Høyer A.P., Jørgensen T., Rank F., and Grandjeau P. Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: A Danish cohort-nested case-control study. BMC Cancer 1 (2001) 8
57. Høyer A.P., Jørgensen T., Rank F., Grandjeau P., and Hartvig H.B. Organochlorines, p53 mutations in relation to breast cancer risk and survival: A Danish cohort-nested case-control study. Breast Cancer Research and Treatment 71 (2002) 59-65
58. Johansen H.C. Danish population history 1600-1939 (2003), University of Southern Denmark Press, Odense
59. Jørgensen T. Epidemiologisk forskning gennem 40 år: Befolkningsundersøgelserne i Glostrup-Center for Sygdomsforebyggelse-Forskningscenter for Forebyggelse og Sundhed. Ugeskrift Læger 166 15-16 (2004) 1425-1428
60. Juel K., and Helweg-Larsen K. The Danish registers of causes of death. Danish Medical Bulletin 46 (1999) 354-357
61. Kamph, L. (2006). Dansk bioanalytikere, 'Østerbroundersøgelsens biobank atter uvurderlig' (The Copenhagen City Heart Study's biobank once again invaluable). http://www.dbio.dk/neobuilder.2006080110383930900056641.html. (Accessed 15 May 2008)
62. Kannel W.B. The Framingham Study: Its 50-year legacy and future promise. Journal of Atherosclerosis and Thrombosis 6 2 (2000) 60-66
63. Keating P., and Cambrosio A. Biomedical platforms. Configurations 8 (2000) 337-387
64. Keating P., and Cambrosio A. Biomedical platforms: Realigning the normal and the pathological in late-twentieth-century medicine (2003), MIT Press, Cambridge, MA
65. Keys A., Menotti A., Aravanis C., Blackburn H., Djordevic B.S., Buzina R., Dontas A.S., Fidanza F., Karvonen M.J., Kimura N., et al. The Seven Countries Study: 2,289 deaths in 15 years. Preventive Medicine 13 2 (1984) 141-154
66. Krieger N. Epidemiology and the web of causation: Has anyone seen the spider?. Social Science and Medicine 39 (1994) 887-903
67. Krieger N. Theories for social epidemiology in the twenty-first century: An ecosocial perspective. International Journal of Epidemiology 30 4 (2001) 668-677
68. Krieger N., Wolff M.S., Hiatt R.A., Rivera M., Vogelman J., and Orentreich N. Breast cancer and serum organochlorines: A prospective study among white, black, and Asian women. Journal of the National Cancer Institute 86 8 (1994) 589-599
69. Lamm G.o.b.o.t.W.E.s.group. The risk-map of Europe. Annals of Medicine 21 3 (1989) 190-192
70. Last J. dictionary of epidemiology (1983), Oxford University Press, New York
71. Latour B. Science in action: How to follow scientists and engineers through society (1987), Open University Press, Milton Keynes
72. Latour B. The pasteurization of France (1988), Harvard University Press, Cambridge, MA
73. Latour B. We had never been modern (1988), Harvard University Press, Cambridge, MA
74. Latour B., and Woolgar S. Laboratory life: The social construction of scientific facts (1979), Sage, Los Angeles
75. Lenoir T. Shaping biomedicine as an information science. In: Bellardo Hahn T., Bowden M.E., and Williams R.V. (Eds). Proceedings of the 1998 Conference on the History and Heritage of Science Information Systems. ASIS Monograph Series (1999), Information Today, Medford, NJ 27-45
76. Loiborg, S., Brøndum-Nielsen, K., Daasnes, C., Melbye, M., Saugmann-Jensen, P., von Linstow, H., Aarø-Hansen, N., & Rasmussen, B. (2002). Redegørelse om biobanker. Forslåg til retlig regulering af biobanker inden for sundhedsområdet. Betænkning nr. 1414. Indenrigs- og Sundhedsministeriet. Copenhagen.
77. Löwy I. Immunotherapy of cancer from Coley's toxins to interferons: Molecularization of a therapeutic practice. In: deChadarevian S., and Kamminga H. (Eds). Molecularizing biology and medicine: New practices and alliances, 1910-1970s (1998), Harwood, Amsterdam 249-271
78. Magnello E. The introduction of mathematical statistics into medical research: The roles of Karl Pearson, Major Greenwood and Austin Bradford Hill. In: Magnello E., and Hardy A. (Eds). The road to medical statistics (2002), Rodopi, Amsterdam 95-123
79. In: Magnello E., and Hardy A. (Eds). The road to medical statistics (2002), Rodopi, Amsterdam
80. Mariotti S., Capocaccia R., Farchi G., Menotti A., Verdecchia A., and Keys A. Differences in the incidence rate of coronary heart disease between North and South European cohorts of the Seven Countries Study as partially explained by risk factors. European Heart Journal 3 (1981) 481-487
81. Marks H. The progress of experiment: Science and therapeutic reform in the United States, 1900-1990 (1997), Cambridge University Press, Cambridge
82. Matthews J.R. Quantification and the quest for medical certainty (1995), Princeton University Press, Princeton, NJ
83. McMahon B., Pugh T., and Ipsen J. Epidemiologic methods (1960), Little, Brown & Company, Boston
84. Melbye M. Registerforskning: Enestående danske muligheder (2001), IT- og Forskningsministeriet, Copenhagen
85. Mendelsohn A. From eradication to equilibrium: How epidemics became complex after World War I. In: Lawrence C., and Weisz G. (Eds). Greater than the parts: Holism in biomedicine, 1920-1950 (1998), Oxford University Press, Oxford 303-331
86. Meulengracht, A., & Madsen, M. (1982). Registre indenfor sundhedsområdet: En oversigt over registreringssystemer, der kan anvendes i epidemiologisk forskning og i sundhedsplanlægning. København: Dansk Institut for Klinisk Epidemiologi.
87. Morabia A. A history of epidemiologic methods and concepts (2005), Birkhäuser, Basel
88. Mortensen P.B. Registerforskning i Danmark. Norsk Epidemiologi 14 1 (2004) 121-124
89. Nevanlinna H., and Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25 (2006) 5912-5919
90. Nielsen, G. (2006). Et tredje brystkræftgen kortlagt. Berlingske Tidende, 1 August, Sect. 1, 3.
91. Nordestgaard B., Agerholm-Larsen B., Wittrup H.H., and Tybjærg-Hansen A. A prospective cardiovascular population study used in genetic epidemiology: The Copenhagen City Heart Study. Scandinavian Journal of Clinical Laboratory Investigation 56 Suppl. 226 (1996) 65-71
92. *1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families. Cancer Research 63 23 (2003) 8153-8157
93. Olsen J.H., Mellemkjær L., and Friis S. Fra kræfttælling til cancerregister. Ugeskrift Læger 166 15/16 (2004) 1458-1461
94. Oppenheimer G.M. Becoming the Framingham Study, 1947-1950. American Journal of Public Health 95 4 (2005) 602-610
95. Pálsson G. Of Althings!. In: Latour B., and Weibel P. (Eds). Making things public (2005), MIT Press, Cambridge, MA 250-257
96. Paneth N., Susser E., and Susser M. Origins and early development of the case-control study. In: Morabia A. (Ed). A history of epidemiologic methods and concepts (2005), Birkhäuser, Basel 291-311
97. Parascandola M. Epidemiology in transition: Tobacco and lung cancer in the 1950s. In: Jorland G., Opinel A., and Weisz G. (Eds). Body counts: Medical quantification in historical and sociological perspectives (2005), McGill-Queen's University Press, Montreal 226-248
98. Parry B. Trading the genome: Investigating the commodification of bio-information (2004), Columbia University Press, New York
99. Parthasarathy S. Architectures of genetic medicine: Comparing genetic testing for breast cancer in the USA and the UK. Social Studies of Science 35 1 (2005) 5-40
100. Pearce S. Collecting as a medium and message. In: Hooper-Greenhill E. (Ed). Museum, media, message (1995), Routledge, London 15-23
101. Pickering A. The mangle of practice: Time, agency & science (1995), University of Chicago Press, Chicago
102. Pickstone J. Ways of knowing (2000), Manchester University Press, Manchester
103. Pickstone J. Working knowledges before and after circa 1800: Practices and disciplines in the history of science, technology and medicine. Isis 98 (2007) 489-516
104. Porter T.M. Trust in numbers: The pursuit of objectivity in science and public life (1995), Princeton University Press, New Jersey
105. Porter T.M. Life insurance, medical testing, and the management of mortality. In: Daston L. (Ed). Biographies of scientific objects (2000), University of Chicago Press, Chicago 226-246
106. Rabinow P. Anthropos today: Reflections on modern equipment (2003), Princeton University Press, Princeton
107. Rheinberger H.-J. Towards a theory of epistemic things: Synthesizing proteins in the test tube (1997), Stanford University Press, Stanford
108. Rose N., and Novas C. Biological citizenship. In: Ong A., and Collier S.J. (Eds). Global assemblages: Technologies, politics, and ethics as anthropological problems (2005), Blackwell, Oxford 439-463
109. Rothman K., and Greenland S. Modern epidemiology (1998), Lippincott, Raven
110. Schnohr P., Jensen G., Lange P., Scharling H., and Appleyard M. The Copenhagen City Heart Study, Østerbroundersøgelsen: Tables with data from the third examination 1991-1994. European Heart Journal 3 Suppl. H (2001) H1-H83
111. Shostak S. The emergence of toxicogenomics: A case study of molecularization. Social Studies of Science 35 3 (2005) 367-403
112. Snedeker S. Pesticides and breast cancer risk: A review of DDT, DDE, and dieldrin. Environmental Health Perspectives 109 Suppl. 1 (2001) 35-47
113. Storm, H. (1991). The Danish Cancer Registry: A self-reporting national cancer registration system with elements of active data collection. In O. Jensen, D. Parkin, R. MacLennan, C. S. Muir, & R. G. Skeet (Eds.), Cancer registration: Principles and methods (pp. 220-236). IARC Monograph No. 95. Lyon: International Agency for Research on Cancer (IARC).
114. Strasser, B. (2006). Collecting and experimenting: The moral economies of biological research, 1960-1980s. In S. de Chadarevian, & H.-J. Rheinberger (Eds.), History and epistemology of molecular biology and beyond: Problems and perspectives (pp. 105-123). Preprint, 310. Berlin: Max Planck Institute for the History of Science.
115. Susser M. What is a cause and how do we know one?. A grammar for pragmatic epidemiology. American Journal of Epidemiology 133 7 (1991) 635-648
116. Susser M. Should the epidemiologist be a social scientist or a molecular biologist?. International Journal of Epidemiology 28 5 (1999) S1019-S1022
117. *1100delC and susceptibility to breast Cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. American Journal of Human Genetics, 74, 1175-1182.
118. *1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genetics, 31, 55-59.
119. Trostle J.A. Epidemiology and culture (2005), Cambridge University Press, New York
120. Tunstall-Pedoe, H. for the WHO MONICA project (Ed.). (2003). MONICA Monograph and multimedia sourcebook. Geneva: World Health Organization.
121. Unger M., and Olsen J. Organochlorine compounds in the adipose tissue of deceased people with and without cancer. Environmental Research 23 2 (1980) 257-263
122. Unger M., Kiaer H., Blichert-Toft M., Olsen J., and Clausen J. Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environmental Research 34 1 (1984) 24-28
123. Unger M., Olsen J., and Clausen J. Organochlorine compounds in the adipose tissue of deceased persons with and without cancer: A statistical survey of some potential confounders. Environmental Research 29 2 (1982) 371-376
124. Vahteristo P., Bartkova J., Eerola H., Syrjäkoski K., Ojala S., Kilpivaara O., Tamminen A., Kononen J., Aittomäki K., Heikkilä P., Holli K., Blomqvist C., Bartek J., Kallioniemi O.P., and Nevanlinna H. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. American Journal of Human Genetics 71 2 (2002) 432-438
125. Vallgårda S. Public health policies: A Scandinavian model?. Scandinavian Journal of Public Health 35 2 (2007) 205-211
126. Vineis P. Proof in observational medicine. Journal of Epidemiology and Community Health 51 (1997) 9-13
127. Vineis P. Causality in epidemiology. In: Morabia A. (Ed). A history of epidemiologic methods and concepts (2005), Birkhäuser, Basel 337-349
128. Waldby C. Stem cells, tissue cultures and the production of biovalue. Health: An Interdisciplinary Journal for the Social Study of Health. Illness and Medicine 6 3 (2002) 305-323
129. Weischer M., Bojesen S.E., Tybærg-Hansen A., Axelsson C.K., and Nordestgaard B.G. Svar (Debat). Ugeskrift for Læger 168 (2006) 3448
130. *1100delC. Journal of Clinical Oncology 25 1 (2007) 57-63 (Epublished 31 July 2006)
131. Weisz G. From clinical counting to evidence-based medicine. In: Jorland G., Opinel A., and Weisz G. (Eds). Body counts: Medical quantification in historical & sociological perspectives (2005), McGill-Queen's University Press, Montreal 377-393